Paperpal Prime Logo

BMC Complementary Medicine and Therapies : Impact Factor & More

eISSN: 2662-7671pISSN: 2662-7671
JournalOpen Access

Key Metrics

CiteScore
6.2
Impact Factor
< 5
Scite Index
0.89 5-Year SI
SJR
Q1Complementary and Alternative Medicine
SNIP
1.47
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on BMC Complementary Medicine and Therapies

BMC Complementary Medicine and Therapies Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2290 | USD 2690 | GBP 1990
Publication Time19
Editorial Review ProcessOpen peer review
General Details
LanguageEnglish
Society/Institute/SponsorISCMR; Cochrane Complementary Medicine
FrequencyContinuous publication
Publication Start Year2020
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 19
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessOpen peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in BMC Complementary Medicine and Therapies ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in BMC Complementary Medicine and Therapies

Protective role of rosmarinic acid against radiation-induced dermatitis: focus on oxidative stress and inflammation.
  • 30 Jun 2026
  • BMC complementary medicine and therapies
Isolation and identification of hasubanan alkaloids having anti-cholinesterase and antioxidant activity from the stem Stephania japonica.
  • 29 Jun 2026
  • BMC complementary medicine and therapies
Retraction Note: In vitro evaluation of Pandanus amaryllifolius ethanol extract for induction of cell death on non-hormone dependent human breast adenocarcinoma MDA-MB-231 cell via apoptosis.
  • 27 Jun 2026
  • BMC complementary medicine and therapies
Protective effects of Tinospora crispa and Tinospora cordifolia extracts against methylglyoxal-induced oxidative stress and apoptosis in hFOB 1.19 cells: ELISA-based evaluation and molecular docking insights with antioxidant enzymes.
  • 24 Jun 2026
  • BMC complementary medicine and therapies
Traditional phytopharmaceutical practices and integrative healthcare perspectives among herbal practitioners: a cross-sectional analysis in Tigray, Ethiopia.
  • 23 Jun 2026
  • BMC complementary medicine and therapies
Patterns of complementary and alternative medicine use and factors influencing its utilization in thyroid cancer: findings from the MASTER study.
  • 23 Jun 2026
  • BMC complementary medicine and therapies
Protective role of rosmarinic acid against radiation-induced dermatitis: focus on oxidative stress and inflammation.
  • 30 Jun 2026
  • BMC complementary medicine and therapies
Isolation and identification of hasubanan alkaloids having anti-cholinesterase and antioxidant activity from the stem Stephania japonica.
  • 29 Jun 2026
  • BMC complementary medicine and therapies
Retraction Note: In vitro evaluation of Pandanus amaryllifolius ethanol extract for induction of cell death on non-hormone dependent human breast adenocarcinoma MDA-MB-231 cell via apoptosis.
  • 27 Jun 2026
  • BMC complementary medicine and therapies
Protective effects of Tinospora crispa and Tinospora cordifolia extracts against methylglyoxal-induced oxidative stress and apoptosis in hFOB 1.19 cells: ELISA-based evaluation and molecular docking insights with antioxidant enzymes.
  • 24 Jun 2026
  • BMC complementary medicine and therapies
Traditional phytopharmaceutical practices and integrative healthcare perspectives among herbal practitioners: a cross-sectional analysis in Tigray, Ethiopia.
  • 23 Jun 2026
  • BMC complementary medicine and therapies
Patterns of complementary and alternative medicine use and factors influencing its utilization in thyroid cancer: findings from the MASTER study.
  • 23 Jun 2026
  • BMC complementary medicine and therapies

FAQs on BMC Complementary Medicine and Therapies